Member Info for nursesteve

Alan shouted that they had the holy grail of cancer treatment but just in case he raised funds and invested in diagnostics. Showing he wasn’t truely convinced (otherwise he would have gone all in with prescision). Chris took over when he was sacked and has delivered exceptional results deepening the value of the science by further developing it showcasing the breadth of its use. She has also brought on board a money man and deal maker. Explicitly stating that there are a number of interested parties but she will only do the right deal at the right time.one that releases and reflects the fully demonstrated value of this platform.

I predict a steady rise this week

Since RH took an interest here I’ve been much more reassured and his timing indicates ‘jam soon’ as he could have stayed on the sidelines but hadn’t The presentation showed the science has become much more compelling. Chris also mentioned briefly the fast track options but the value is in demonstrating we are a platform and the beast in clinic early next year will prove that - I’m a long term holder who will hold GLA

Both the times and the daily telegraph have stories on their front pages today noting how the PSA test can be used selectively and should be part of a national screening program for prostate cancer. It would be great if we could feed them their next news article how the Episwitch PSE test can improve those results!

Half the cost and improved drug delivery as it releases the correct amount of each payload simultaneously to better target the tumour

All seems very good but well above my level of understanding. I did pick up on the reason it’s better to have a duel payload as they have a synergetic effect. Seems to be in line with what most oncologist do prescribe - combinations of drugs to treat their patients.

RNS in the morning announcing partnership deals followed by the science bit later and a while lot of questions from investors! 🤞🤞🤞 😜

Ticking up nicely - good volume and steady rise 👍🏻 😊

Simon has been very busy for a while now 🤔😉👍 what comes first early approval? Partnership? Bid? Nicely lining up 🦆 🦆🦆

If Avacta wasn’t on ‘big farms’ radar before it surely is now! Excellent RNS nice and succinct

The duel payload use of the platform widens Avacta exclusive IP value of the platform as numerous combined anti cancer drugs can now be given via a single FAP cleaveable payload, which (in combination) is how clinicians such as Chris usually treat cancer.

Very happy with the clinical results - early approval incoming?

If Avacta do receive an offer from big Pharma do they have to put it to shareholders ? Or if they believe that it’s in shareholders best interests to not even consider an Offer? Can they keep going with their own plans ? 🤔

Thanks bootnk19222 for the info! ☺️

What’s this? https://avacta.com/stage-products/ava6207/ 🤔

Great start to the news rich period we were promised by Chris ☑️ hope we see signing of the deals 💰 that should follow! GLA

It works! So what’s next? 🤔 ? 💰

Whilst it’s nice to speculate I’m looking forward to the official release of news. Is this the time to buy the rumour? 🤔

Definitely on the home straight now! 🚗

- can’t see it being another 14 years! 😜🤞

Don’t worry it will be back! 😉